GeneReach Biotechnology (Taiwan) Probability of Future Stock Price Finishing Over 26.62
| 4171 Stock | TWD 26.35 0.10 0.38% |
GeneReach |
GeneReach Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GeneReach Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GeneReach Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| GeneReach Biotechnology generated a negative expected return over the last 90 days | |
| About 35.0% of the company shares are owned by insiders or employees |
GeneReach Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of GeneReach Stock often depends not only on the future outlook of the current and potential GeneReach Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GeneReach Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.8 M |
GeneReach Biotechnology Technical Analysis
GeneReach Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. GeneReach Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GeneReach Biotechnology. In general, you should focus on analyzing GeneReach Stock price patterns and their correlations with different microeconomic environments and drivers.
GeneReach Biotechnology Predictive Forecast Models
GeneReach Biotechnology's time-series forecasting models is one of many GeneReach Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary GeneReach Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about GeneReach Biotechnology
Checking the ongoing alerts about GeneReach Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for GeneReach Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| GeneReach Biotechnology generated a negative expected return over the last 90 days | |
| About 35.0% of the company shares are owned by insiders or employees |
Additional Tools for GeneReach Stock Analysis
When running GeneReach Biotechnology's price analysis, check to measure GeneReach Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneReach Biotechnology is operating at the current time. Most of GeneReach Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneReach Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneReach Biotechnology's price. Additionally, you may evaluate how the addition of GeneReach Biotechnology to your portfolios can decrease your overall portfolio volatility.